Greiner Bio-One North America, Inc. – FDA 483, Oct 29, 2021
An FDA inspection of Greiner Bio-One North America, Inc., a medical device manufacturer in Monroe, NC, revealed significant deficiencies in their quality system. Observations included inadequate procedures for corrective and preventive actions (CAPA), insufficient training criteria for their eCAPA system, and failures in maintaining quality system records, particularly concerning electronic and hardcopy documentation. These issues indicate a need for improved procedural controls and documentation practices.
ID · d4c755b6-4e0b-4e58-b9c7-77a8b9ec9342
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.